An experimental treatment reduces seizures and other symptoms in children with a type of epilepsy called Dravet syndrome.

An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children ...

Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are ...

A first-in-class gene-regulating therapy cut seizures by up to 91% in children with Dravet syndrome in extension studies, ...

Researchers identify prochlorperazine as a potential new treatment for temporal lobe epilepsy by restoring the KCC2 chloride ...

Preliminary trials into Zorevunersen find drug to be safe and well tolerated by those with Dravet syndrome ...

A Phase I/IIa clinical trials co-led by Linda Laux, MD, from Ann & Robert H. Lurie Children's Hospital of Chicago, show that ...

Researchers discover that KCNQ2/3 potassium channels must be functional to reach their proper location in the brain, with major implications for treating epilepsy.

Please provide your email address to receive an email when new articles are posted on . Neurological disorders like epilepsy can have significant, life-altering implications for patients, their ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

A few years ago, I climbed over a gate and found myself gazing down at a valley. After I'd been walking for a few minutes, looking at the fields and the sky, there was a shift in my perception.